<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.5"?>
<!-- generated-on="2026-06-01T23:30:43+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.5" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/minimal-access-vs-open-hysterectomy-in-endometrial-cancer-a-critical-synthesis-of-surgical-and-survival-outcomes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T13:00:51-07:00</news:publication_date><news:title>Minimal Access vs. Open Hysterectomy in Endometrial Cancer: A Critical Synthesis of Surgical and Survival Outcomes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/maternal-fetal-alloimmunity-and-gestational-outcomes-assessing-anti-hla-antibodies-as-a-risk-factor-for-fetal-growth-restriction/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T12:20:38-07:00</news:publication_date><news:title>Maternal-Fetal Alloimmunity and Gestational Outcomes: Assessing Anti-HLA Antibodies as a Risk Factor for Fetal Growth Restriction</news:title></news:news></url>
<url><loc>https://news.medxy.ai/postmarketing-data-link-fezolinetant-primarily-to-early-transaminase-elevations-rather-than-overt-liver-injury/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T12:03:35-07:00</news:publication_date><news:title>Postmarketing Data Link Fezolinetant Primarily to Early Transaminase Elevations Rather Than Overt Liver Injury</news:title></news:news></url>
<url><loc>https://news.medxy.ai/targeted-galectin-3-inhibition-for-portal-hypertension-insights-from-the-navigate-trial-and-belapectins-role-in-mash-cirrhosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T11:38:15-07:00</news:publication_date><news:title>Targeted Galectin-3 Inhibition for Portal Hypertension: Insights from the NAVIGATE Trial and Belapectin’s Role in MASH Cirrhosis</news:title></news:news></url>
<url><loc>https://news.medxy.ai/galectin-3-inhibition-in-mash-cirrhosis-synthesizing-evidence-from-the-navigate-trial-and-emerging-therapeutics/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T11:02:58-07:00</news:publication_date><news:title>Galectin-3 Inhibition in MASH Cirrhosis: Synthesizing Evidence from the NAVIGATE Trial and Emerging Therapeutics</news:title></news:news></url>
<url><loc>https://news.medxy.ai/belapectin-for-the-prevention-of-esophageal-varices-in-mash-cirrhosis-insights-from-the-navigate-phase-2b-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T10:59:12-07:00</news:publication_date><news:title>Belapectin for the Prevention of Esophageal Varices in MASH Cirrhosis: Insights from the NAVIGATE Phase 2b Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/exercise-may-be-a-disease-modifying-strategy-in-chronic-pancreatitis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T10:55:49-07:00</news:publication_date><news:title>Exercise May Be a Disease-Modifying Strategy in Chronic Pancreatitis</news:title></news:news></url>
<url><loc>https://news.medxy.ai/therapeutic-mobilization-how-physical-activity-reprograms-the-pancreatic-immune-microenvironment-to-combat-chronic-pancreatitis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T10:23:30-07:00</news:publication_date><news:title>Therapeutic Mobilization: How Physical Activity Reprograms the Pancreatic Immune Microenvironment to Combat Chronic Pancreatitis</news:title></news:news></url>
<url><loc>https://news.medxy.ai/fermentable-fiber-subtypes-in-crohns-disease-from-primary-prevention-to-mechanistic-regulation-of-the-gut-immune-axis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T10:18:20-07:00</news:publication_date><news:title>Fermentable Fiber Subtypes in Crohn’s Disease: From Primary Prevention to Mechanistic Regulation of the Gut-Immune Axis</news:title></news:news></url>
<url><loc>https://news.medxy.ai/microbiome-mediated-prevention-the-role-of-fermentable-fibers-in-mitigating-crohns-disease-risk-and-gut-barrier-dysfunction/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T09:01:47-07:00</news:publication_date><news:title>Microbiome-Mediated Prevention: The Role of Fermentable Fibers in Mitigating Crohn’s Disease Risk and Gut Barrier Dysfunction</news:title></news:news></url>
<url><loc>https://news.medxy.ai/fermentable-fibers-and-crohns-disease-prevention-multi-omic-insights-into-%ce%b2-glucan-inulin-and-gut-barrier-integrity/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-06-01T08:59:23-07:00</news:publication_date><news:title>Fermentable Fibers and Crohn’s Disease Prevention: Multi-Omic Insights into β-Glucan, Inulin, and Gut Barrier Integrity</news:title></news:news></url>
<url><loc>https://news.medxy.ai/avoiding-intensive-systolic-blood-pressure-lowering-after-successful-thrombectomy-may-improve-1-year-stroke-recovery-the-optimal-bp-extension/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T22:00:37-07:00</news:publication_date><news:title>Avoiding Intensive Systolic Blood Pressure Lowering After Successful Thrombectomy May Improve 1-Year Stroke Recovery: The OPTIMAL-BP Extension</news:title></news:news></url>
<url><loc>https://news.medxy.ai/teleneurology-in-rural-general-practice-improved-triage-but-did-not-reduce-secondary-care-use-in-a-stepped-wedge-randomized-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T20:04:58-07:00</news:publication_date><news:title>Teleneurology in Rural General Practice Improved Triage but Did Not Reduce Secondary Care Use in a Stepped-Wedge Randomized Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/what-the-new-thyroid-surgery-consensus-means-for-same-day-care/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T19:56:25-07:00</news:publication_date><news:title>What the New Thyroid Surgery Consensus Means for Same-Day Care</news:title></news:news></url>
<url><loc>https://news.medxy.ai/sstr2-antagonism-restored-glucagon-responses-during-experimental-hypoglycaemia-in-adults-with-long-standing-type-1-diabetes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T19:26:52-07:00</news:publication_date><news:title>SSTR2 Antagonism Restored Glucagon Responses During Experimental Hypoglycaemia in Adults With Long-Standing Type 1 Diabetes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/in-transition-age-childhood-onset-gh-deficiency-glucagon-test-results-reflect-pituitary-damage-more-than-body-mass-index/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T18:56:20-07:00</news:publication_date><news:title>In Transition-Age Childhood-Onset GH Deficiency, Glucagon Test Results Reflect Pituitary Damage More Than Body Mass Index</news:title></news:news></url>
<url><loc>https://news.medxy.ai/less-than-5-kg-of-gestational-weight-gain-in-type-2-diabetes-was-linked-to-lower-risk-of-lga-hypertensive-disorders-nicu-admission-and-cesarean-delivery/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T18:54:50-07:00</news:publication_date><news:title>Less Than 5 kg of Gestational Weight Gain in Type 2 Diabetes Was Linked to Lower Risk of LGA, Hypertensive Disorders, NICU Admission, and Cesarean Delivery</news:title></news:news></url>
<url><loc>https://news.medxy.ai/optimizing-gestational-weight-gain-in-type-2-diabetes-clinical-evidence-for-restricted-targets-and-perinatal-benefits/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T18:29:52-07:00</news:publication_date><news:title>Optimizing Gestational Weight Gain in Type 2 Diabetes: Clinical Evidence for Restricted Targets and Perinatal Benefits</news:title></news:news></url>
<url><loc>https://news.medxy.ai/pulmonary-artery-pressure-falls-after-arni-and-mra-initiation-but-not-sglt2-inhibitors-in-hemodynamically-monitored-heart-failure-insights-from-guide-hf/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T18:04:11-07:00</news:publication_date><news:title>Pulmonary Artery Pressure Falls After ARNI and MRA Initiation, but Not SGLT2 Inhibitors, in Hemodynamically Monitored Heart Failure: Insights From GUIDE-HF</news:title></news:news></url>
<url><loc>https://news.medxy.ai/premature-natural-menopause-signals-higher-lifetime-coronary-heart-disease-risk-in-both-black-and-white-women/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T14:52:38-07:00</news:publication_date><news:title>Premature Natural Menopause Signals Higher Lifetime Coronary Heart Disease Risk in Both Black and White Women</news:title></news:news></url>
<url><loc>https://news.medxy.ai/higher-hospital-myectomy-volume-was-linked-to-fewer-early-complications-in-dutch-hypertrophic-obstructive-cardiomyopathy-surgery/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T11:08:58-07:00</news:publication_date><news:title>Higher Hospital Myectomy Volume Was Linked to Fewer Early Complications in Dutch Hypertrophic Obstructive Cardiomyopathy Surgery</news:title></news:news></url>
<url><loc>https://news.medxy.ai/higher-interleukin-6-levels-predict-broad-cardiovascular-risk-and-mortality-across-diverse-cohorts/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:51:38-07:00</news:publication_date><news:title>Higher Interleukin-6 Levels Predict Broad Cardiovascular Risk and Mortality Across Diverse Cohorts</news:title></news:news></url>
<url><loc>https://news.medxy.ai/genome-first-data-suggest-familial-hypercholesterolemia-is-equally-prevalent-across-african-and-european-ancestry-groups-but-underclassified-in-african-ancestry-patients/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:50:13-07:00</news:publication_date><news:title>Genome-First Data Suggest Familial Hypercholesterolemia Is Equally Prevalent Across African and European Ancestry Groups, but Underclassified in African Ancestry Patients</news:title></news:news></url>
<url><loc>https://news.medxy.ai/addressing-the-equity-gap-in-familial-hypercholesterolemia-comparative-insights-into-african-and-european-ancestry-populations/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:48:52-07:00</news:publication_date><news:title>Addressing the Equity Gap in Familial Hypercholesterolemia: Comparative Insights into African and European Ancestry Populations</news:title></news:news></url>
<url><loc>https://news.medxy.ai/beyond-the-diagnosis-addressing-the-persistent-risk-of-suicidal-self-directed-violence-in-veterans-with-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:42:18-07:00</news:publication_date><news:title>Beyond the Diagnosis: Addressing the Persistent Risk of Suicidal Self-Directed Violence in Veterans with Cancer</news:title></news:news></url>
<url><loc>https://news.medxy.ai/longitudinal-suicide-risk-in-veterans-with-cancer-a-comprehensive-synthesis-of-risk-factors-and-temporal-trends/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:38:55-07:00</news:publication_date><news:title>Longitudinal Suicide Risk in Veterans with Cancer: A Comprehensive Synthesis of Risk Factors and Temporal Trends</news:title></news:news></url>
<url><loc>https://news.medxy.ai/longitudinal-risk-for-suicidal-self-directed-violence-among-veterans-with-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T10:07:52-07:00</news:publication_date><news:title>Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer</news:title></news:news></url>
<url><loc>https://news.medxy.ai/polygenic-scores-often-rival-recurrent-cnvs-for-psychiatric-risk-stratification-but-both-add-clinical-insight/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T09:48:08-07:00</news:publication_date><news:title>Polygenic Scores Often Rival Recurrent CNVs for Psychiatric Risk Stratification, but Both Add Clinical Insight</news:title></news:news></url>
<url><loc>https://news.medxy.ai/integrating-rare-and-common-variants-the-synergistic-role-of-rcnvs-and-polygenic-scores-in-psychiatric-risk-stratification/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T09:25:20-07:00</news:publication_date><news:title>Integrating Rare and Common Variants: The Synergistic Role of rCNVs and Polygenic Scores in Psychiatric Risk Stratification</news:title></news:news></url>
<url><loc>https://news.medxy.ai/four-oxygenation-trajectories-define-reproducible-clinical-archetypes-in-persistent-acute-respiratory-failure/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-31T09:17:31-07:00</news:publication_date><news:title>Four Oxygenation Trajectories Define Reproducible Clinical Archetypes in Persistent Acute Respiratory Failure</news:title></news:news></url>
<url><loc>https://news.medxy.ai/liberal-transfusion-still-appears-favored-in-myocardial-infarction-with-anemia-regardless-of-critical-illness-status/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-05-30T17:18:45-07:00</news:publication_date><news:title>Liberal Transfusion Still Appears Favored in Myocardial Infarction With Anemia, Regardless of Critical Illness Status</news:title></news:news></url>
</urlset>
